Greg Yap

Partner · Menlo Ventures · Palo Alto, United States

Decision makerActive

Email

Verified, deliverable email

Unlock Greg and the rest of Menlo Ventures

One payment, no subscription - every verified contact at Menlo Ventures drops into your wallet.

Partner at Menlo Ventures

Stages: Series A, Seed
Sectors: Health tech
Cheque size: €7.4M–€13.8M
Location: Palo Alto, United States
Freshness: Verified today
Fund size: $500M

Notable investments

Aurora TherapeuticsSeed · $16M · 2026
Chai DiscoverySeries B · $130M · 2025
CartwheelSeries B · $35M · 2025
Heidi HealthSeries A · $17M · 2025
Clear LabsSeries D · $30M · 2025
VilyaSeries A · $21M · 2024
Xaira TherapeuticsSeries A · $1B · 2024
Delfi DiagnosticsSeries B · $230M · 2022

Frequently co-invests with

Robert NelsenARCH Venture Partners2×Akshay KothariAmjad MasadAnnie LamontOak HC/FTAydin SenkutFelicis VenturesBrian KeilAlumni VenturesChris SklarinAlumni VenturesCraig CummingsMoonshots CapitalDaniel LevineAccelDrew HoustonElena (Lainy) PainterCraft VenturesElena VibochGeneral Catalyst

Background

InvestorXaira Therapeutics2024–present
Board Member & InvestorCartwheel2023–present
Board Member & InvestorVilya2023–present
Board Member & InvestorKoala Health2022–present
Board Member & InvestorOphelia2021–present
InvestorScribe Therapeutics2021–present
Board Observer & InvestorGenesis Therapeutics2020–present
Board Member & InvestorH12020–present
Board Member & InvestorParticle Health2020–present
Health Innovators FellowThe Aspen Institute2019–present
Board Member & InvestorDelfi Diagnostics2019–present
Board Member & InvestorRiva Health2019–present
InvestorEncoded Therapeutics Inc.2019–present
InvestorBenchling2019–present
Board Member & InvestorClear Labs2019–present
InvestorPliant Therapeutics2018–present
Board Member & InvestorEpiodyne2018–present
PartnerMenlo Ventures2017–present
InvestorRecursion2017–present
Board MemberOutward Bound California2013–present
CEO & Co-founderPyrAmes2016–2017
Entrepreneur in ResidenceIllumina Ventures2016–2017
CEO & Co-founderBiodesy (now BlueLight Therapeutics, Inc.)2013–2016
Entrepreneur in ResidenceGE2013–2013
Lifecycle Leader (SVP), Advanced AssaysRoche Diagnostics2010–2013
Lifecycle Leader (SVP), Advanced AssaysVentana Medical Systems2010–2013
Chief Operating OfficerCellPoint Diagnostics2008–2009
Vice President, Molecular DiagnosticsAffymetrix2006–2008
Vice President, DNA ProductsAffymetrix2001–2005
Director, Business DevelopmentAffymetrix1997–1999
Business AnalystMcKinsey1995–1997

Greg Yap's colleagues at Menlo Ventures

Every verified colleague at Menlo Ventures

One payment, no subscription - they all drop into your wallet.

Tim TullyPartner, Menlo Ventures

Aunkur AryaVenture Partner, Menlo Ventures

Andreas VandrisInvestor, Menlo Ventures

Grace GePrincipal, Menlo Ventures

Tyler SosinPrincipal, Menlo Ventures

Avery MoreVenture Partner, Menlo Ventures

Croom BeattyPartner, Menlo Ventures

Shawn CarolanPartner, Menlo Ventures

Venky GanesanPartner, Menlo Ventures

Steve SloanePartner, Menlo Ventures

Naomi Pilosof IonitaPartner, Menlo Ventures

Amy WuGeneral Partner, Menlo Ventures

Mark SiegelPartner, Menlo Ventures

Matt MurphyPartner, Menlo Ventures

See all 15 at Menlo Ventures →

Related lists

Health tech investors Series A Health tech in United States Seed Health tech in United States

Similar investors

Rishi GuptaPartner, OrbiMed

Ralph (Chris) ChristoffersenPartner, Morgenthaler Ventures

Blake PateAnalyst, Bios Partners

Raj ParekhGeneral Partner, Advent Life Sciences

Reinhard VogtVenture Partner, Dynamk Capital

Richard WellsManaging Director, Insight Partners

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you Greg Yap? Request removal of this listing.